溶解性 | DMSO 38 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
存贮条件 | 储存温度-20°C |
备注 | BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2. |
生化机理 | BMS-707035 is an HIV-1 integrase (IN) inhibitor. BMS-707035 was scheduled to be evaluated in a Phase II study to assess the antiretroviral activity, safety, pharmacodynamics, and pharmacokinetics in 50 HIV-infected subjects using a 10-day randomized, double-blind, placebo-controlled, ascending multiple-dose study design. |
别名 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin;4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin |
BMS-707035,可逆的HIV-1整合酶(IN)抑制剂
BMS-707035 (订货以英文为准)
编号:B126158
CAS号:729607-74-3
分子式:C17H19FN4O5S
分子量:410.42
产品名称 | BMS-707035 |
中文名称 | BMS-707035,可逆的HIV-1整合酶(IN)抑制剂 |
CAS号 | 729607-74-3 |
分子式(M.F.) | C17H19FN4O5S |
分子量(M.W.) | 410.42 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品